Lunai Bioworks names 10 defendants in alleged naked short-selling fraud lawsuit

PUBT · 1d ago
Lunai Bioworks names 10 defendants in alleged naked short-selling fraud lawsuit
  • Lunai Bioworks filed a first amended complaint in Delaware federal court naming 10 defendants over an alleged coordinated naked short-selling scheme.
  • Suit seeks treble damages under federal RICO, citing alleged failures to deliver of 29.6 million shares, or more than 81% outstanding.
  • Complaint alleges short sales violated Regulation SHO from November 2025 through May 2026, pointing to 554,032,865 shares traded on March 17, 2026.
  • Claims include securities fraud, market manipulation, civil conspiracy, racketeering, common law fraud, tortious interference; jury trial demanded.
  • Plaintiff signals more defendants may be added as discovery and trading-data analysis continues.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608040920PR_NEWS_USPR_____LA18816) on August 04, 2026, and is solely responsible for the information contained therein.